Arcellx Inc [ACLX] stock is trading at $67.58, up 4.65%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ACLX shares have gain 3.35% over the last week, with a monthly amount drifted -14.54%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Arcellx Inc [NASDAQ: ACLX] stock has seen the most recent analyst activity on October 08, 2024, when Redburn Atlantic initiated its Buy rating and assigned the stock a price target of $109. On May 31, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $70 on the stock. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $81 on March 07, 2024. Needham reiterated its recommendation of a Buy and raised its price target to $71 on January 04, 2024. Scotiabank started tracking with a Sector Outperform rating for this stock on December 19, 2023, and assigned it a price target of $66. In a note dated October 30, 2023, TD Cowen initiated an Outperform rating.
Arcellx Inc [ACLX] stock has fluctuated between $47.88 and $107.37 over the past year. Currently, Wall Street analysts expect the stock to reach $111.6 within the next 12 months. Arcellx Inc [NASDAQ: ACLX] shares were valued at $67.58 at the most recent close of the market. An investor can expect a potential return of 65.14% based on the average ACLX price forecast.
Analyzing the ACLX fundamentals
Arcellx Inc [NASDAQ:ACLX] reported sales of 155.82M for the trailing twelve months, which represents a growth of 74.03%. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -0.45%, Pretax Profit Margin comes in at -0.25%, and Net Profit Margin reading is -0.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.05, Equity is -0.08 and Total Capital is -0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 65.87 points at the first support level, and at 64.16 for the second support level. However, for the 1st resistance point, the stock is sitting at 68.66, and for the 2nd resistance point, it is at 69.73.
Ratios To Look Out For
For context, Arcellx Inc’s Current Ratio is 4.29. Further, the Quick Ratio stands at 4.29, while the Cash Ratio is 1.18. Considering the valuation of this stock, the price to sales ratio is 23.45, the price to book ratio is 7.55.
Transactions by insiders
Recent insider trading involved Patel Kavita, Director, that happened on Jan 14 ’25 when 1500.0 shares were sold. CHIEF MEDICAL OFFICER, Heery Christopher completed a deal on Jan 07 ’25 to sell 4230.0 shares. Meanwhile, CHIEF MEDICAL OFFICER Heery Christopher sold 3553.0 shares on Jan 08 ’25.
